However, when we measured the combined positive score focusing on PD-L1-positive tumor cells and PD-L1-positive TAMs (PD-L1 CPS), yielding the median PD-L1 CPS of 64.0% with a range of 0.9 to 122.2%. The gene discussed is CD274; the disease is neoplasm.